The Australian government has issued a warning to medical practitioners regarding the rapid implementation of artificial intelligence (AI) scribes, citing severe privacy risks and a profound lack of regulatory oversight. These tools, which record and summarize consultations between doctors and patients, are increasingly common in general practices, yet they currently operate in a regulatory grey area that has raised concern within the federal health department.
According to internal briefing documents prepared for Senate estimates, the adoption of AI scribes has surged dramatically in recent years. In mid-2026, approximately 40% of Australian general practitioners (GPs) were utilizing the technology during consultations, a significant rise from the 22% reported in August 2024. Despite this widespread adoption, regulators have warned that the current deployment of these tools resembles a "Wild West" scenario, lacking centralized supervision and standardized safeguards.
A key concern revolves around the processing and potential storage of highly sensitive patient data offshore. Under current Australian privacy regulations, sensitive health information should remain within domestic borders unless patients explicitly consent to overseas transmission. However, many AI scribe systems process audio recordings in real time using international cloud networks. Privacy advocates and authorities have expressed concern that patient consultations are being transcribed and, in some cases, used to train AI models without the patient's explicit knowledge or informed consent.
Furthermore, the Therapeutic Goods Administration (TGA), Australia's medical regulator, only classifies and monitors AI scribes as "medical devices" if they have a designated therapeutic function. Many AI developers exploit this distinction, marketing their platforms as administrative assistants to bypass rigorous regulatory assessments. This leaves medical practices vulnerable to software that may not meet stringent security standards.
Beyond data security, the clinical accuracy of AI-generated records remains a critical concern. Research indicates that AI scribes are susceptible to "hallucinations," wherein the system invents details, introduces factual errors, or omits crucial clinical facts from the medical record. Health department officials have reiterated that clinicians must not rely blindly on automated transcripts; rather, doctors bear ultimate legal responsibility for the integrity of patient records and must carefully review and verify every AI-generated summary before finalizing it.
To address these mounting risks, health regulators are advising medical practices to consult with their Medical Defence Organisations and obtain independent legal counsel. As the government contemplates introducing formal legislative safeguards, medical practitioners are urged to prioritize patient transparency, ensuring that consent is systematically obtained and that patients retain the right to refuse AI recording without compromising their care.